Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

Completed

Conditions studied: Breast Cancer

In brief

In this research study, the investigators are testing a new type of breast camera, called Molecular Breast Imaging, to see if it can find tumors in the subject's breast.

Key facts

Study ID

NCT00890994

Run by

Mayo Clinic

People needed

200

Starts

2009-01-19

Expected to finish

2016-11-14

Last updated by the study team

2017-03-22

Who can join

Age: 25 and older, up to 90. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with a breast lesion suspicious for DCIS who are scheduled for a stereotactic breast biopsy.
• Lesion must be considered suggestive or highly suggestive of malignancy according to the Breast Imaging Reporting and Data System Atlas criteria (BIRADS 4 or 5).
• Women between 25 and 90 years of age.

You may not qualify if…

• Unable to understand or sign a consent form.
• Pregnant or lactating.
• Physically unable to sit upright and still for 30-40 minutes.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.